2020 Part D EOB Exhibit B
Exhibit B. Examples that show different versions of Section 1 (the list of prescriptions)
NOTE: The examples in this exhibit have been designed to illustrate some of the main variations in model language for Section 1 of the draft revised Model Part D Explanation of Benefits (EOB). This section shows the list of prescriptions filled by a plan member.
These examples of Section 1 use numbers for the year 2020 and placeholders for the names of drugs. To help show how Section 1 would look in an actual Part D EOB, the examples include fictional information for the rest of the prescription-related text
[Example 1: Deductible payment stage, no payments from plan or others] 3
[Example 3: A separate chart (Chart 2) for prescriptions covered by Supplemental Drug Coverage] 9
[Example 4: Excerpt from Chart 1 showing notes about changes to the formulary] 11
Examples 1 and 2 are designed to illustrate differences in the wording of the text that explains the total amounts which appear at the bottom of the Chart 1 list of prescriptions. These examples are for plan members who have no supplemental drug coverage. Each is in a different payment stage:
Example 1 shows a version of Section 1 for a plan member who is in the deductible payment stage. This member receives no payments from the plan or from third parties.
Example 2 shows a version of Section 1 for a plan member who is in the initial coverage period. This member receives payments from the plan, from the Extra Help program (these payments count toward out-of-pocket costs), and from Worker’s Compensation (these payments do not count toward out-of-pocket costs).
SECTION 1. Your prescriptions during the past month
Chart 1 shows your prescriptions for covered Part D drugs for the past month.
Please look over this information about your prescriptions to be sure it is correct. If you have any questions or think there is a mistake, Section 5 tells what you should do.
CHART 1. Your prescriptions for covered Part D drugs March 2020 |
|
|
|
Plan paid
|
You paid |
Other payments (made by programs or organizations; see Section 3) |
|
{insert name of first drug} 40 mg tabs 03/09/20, ABC Pharmacy Rx# 106663421555, 30 day supply Negotiated Price Change (01/01/2020 to date): $104 increase. There are lower cost therapeutic alternatives available. Please contact your provider for these options. |
$0.00 |
$45.18 |
$0.00 |
{insert name of second drug} 25 mg caps 03/09/20, ABC Pharmacy Rx# 349000711222, 30 day supply |
$0.00 |
$13.80 |
$0.00 |
TOTALS for the month of March 2020: Your “out-of-pocket costs” amount is $58.98. (This is the amount you paid this month ($58.98) plus the amount of “other payments” made this month that count toward your “out-of-pocket costs” ($0.00). See definitions in Section 3.) Your “total drug costs” amount is $58.98. (This is the total for this month of all payments made for your drugs by the plan ($0.00) and you ($58.98) plus “other payments” ($0.00).) |
$0.00 (total for the month) |
$58.98 (total for the month) |
$0.00 (total for the month)
|
(continued)
Year-to-date totals 1/1/20 through 3/31/2020 |
Plan paid
|
You paid
|
Other payments (made by programs or organizations; see Section 3) |
Your year-to-date amount for “out-of-pocket costs” is $58.98. Your year-to-date amount for “total drug costs” is $58.98. For more about “out-of-pocket costs” and “total drug costs,” see Section 3. |
$0.00 (year-to-date total) |
$58.98 (year-to-date total) |
$0.00 (year-to-date total) |
SECTION 1. Your prescriptions during the past month
Chart 1 shows your prescriptions for covered Part D drugs for the past month.
Please look over this information about your prescriptions to be sure it is correct. If you have any questions or think there is a mistake, Section 5 tells what you should do.
CHART 1. Your prescriptions for covered Part D drugs March 2020 |
|
|
|
Plan paid
|
You paid |
Other payments (made by programs or organizations; see Section 3) |
|
{insert name of first drug} inj 100 u/ml 03/09/20, ABC Pharmacy Rx# 124868934511, 15 day supply Negotiated Price Change (01/01/2020 to date): $104 increase. There are lower cost therapeutic alternatives available. Please contact your provider for these options. |
$107.11 |
$21.42
|
$14.28 (paid by “Extra Help”) |
{insert name of second drug} 240 mg caps 03/12/20, Springfield Drugs Rx# 316582122880, 30 day supply |
$6.60 |
$1.32
|
$2.26 (paid by “Extra Help”) |
{insert name of third drug} 150 mg tabs 03/15/20, ABC Pharmacy Rx# 632005552144, 30 day supply
|
$326.90
|
$10.00
|
$43.59 (paid by “Extra Help”) $65.38
(continued) |
{insert name of fourth drug} 50 mg tabs 03/15/20, ABC Pharmacy Rx# 529042917765, 30 day supply Negotiated Price Change (01/01/2020 to date): $104 increase. There are lower cost therapeutic alternatives available. Please contact your provider for these options. NOTE: Beginning on December 1, 2020, step therapy will be required for this drug. See Section 4 for details. |
$60.17 |
$12.03
|
$8.02 (paid by “Extra Help”) |
{insert name of first drug} 100 u/ml 03/15/20, ABC Pharmacy Rx# 124868900912, 15 day supply |
$107.11 |
$21.42
|
$14.28 (paid by “Extra Help”) |
TOTALS for the month of March 2020: Your “out-of-pocket costs” amount is $148.62. (This is the amount you paid this month ($66.19) plus the amount of “other payments” made this month that count toward your “out-of-pocket costs” ($82.43). See definitions in Section 3.) Your “total drug costs” amount is $821.89. (This is the total for this month of all payments made for your drugs by the plan ($607.89) and you ($66.19) plus “other payments” ($147.81).)
|
$607.89 (total for the month)
|
$66.19 (total for the month)
|
$147.81 (total for the month) (Of this amount, $82.43 counts toward your “out-of pocket costs. See definitions in Section 3.)
|
(continued)
Year-to-date totals as of 9/30/20 |
Plan paid
|
You paid
|
Other payments (made by programs or organizations; see Section 3) |
Your year-to-date amount for “out-of-pocket costs” is $690.80. Your year-to-date amount for “total drug costs” is $2,136.26. For more about “out-of-pocket costs” and “total drug costs,” see Section 3. |
$1,314.70 (year-to-date total) |
$445.20 (year-to-date total) |
$376.36 (year-to-date total) (Of this amount, $245.60 counts toward your “out-of pocket costs.” See definitions in Section 3.) |
Example 3 that follows shows a version of Chart 2, which is used to show prescriptions that are covered under the plan’s Supplemental Drug Coverage. This chart follows Chart 1 (it comes immediately after the summary of year-to-date totals).
Showing a separate chart for prescriptions covered under the plan’s Supplemental Drug Coverage helps reduce potential confusion by emphasizing that payments for these prescriptions do not count toward members’ out-of-pocket costs or total drug costs.
NOTE: When Chart 2 is included in an EOB, the following sentence is added to the first bulleted point in the introductory section of Chart 1: “(Prescriptions for drugs covered by our plan’s Supplemental Drug Coverage are shown separately in Chart 2).”
CHART 2. Your prescriptions for drugs covered by our plan’s Supplemental Drug Coverage March 2020
|
|
|
|
Plan paid
|
You paid |
Other payments (made by programs or organizations; see Section 3) |
|
{insert name of drug} 0.5 mg 03/01/20, ABC Pharmacy Rx# 836725300111, 30 day supply Negotiated Price Change (01/01/2020 to date): $104 increase. There are lower cost therapeutic alternatives available. Please contact your provider for these options. |
$2.80 |
$5.00 |
$0.00 |
Totals for the month of March 2020
|
$2.80 $5.00 $0.00 These payments do not count toward your “out-of-pocket costs” or your “total drug costs” because they are for drugs that are not generally covered by Medicare. (See definitions in Section 3.) |
Example 4 shows how explanatory notes are used in Section 1. These notes can provide members additional information related to a prescription, such as notes that highlight general prices increases for that drug, or when a payment for a drug does not count toward out-of-pocket costs, or the drug is only partially covered because it is a compound drug that includes non-Part D drugs. The plan may also suggest lower-cost alternatives that a member and his/her doctor might consider in this section.
SECTION 1. Your prescriptions during the past month
Chart 1 shows your prescriptions for covered Part D drugs for the past month.
Please look over this information about your prescriptions to be sure it is correct. If you have any questions or think there is a mistake, Section 5 tells what you should do.
CHART 1. Your prescriptions for covered Part D drugs March 2020 |
|
|
|
Plan paid
|
You paid |
Other payments (made by programs or organizations; see Section 3) |
|
{insert name of first drug} 30 mg tabs 03/11/20, ABC Pharmacy Rx# 222003740005, 30 day supply Negotiated Price Change (01/01/2020 to date): $104 increase. There are lower cost therapeutic alternatives available. Please contact your provider for these options. NOTE: Beginning on December 1, 2020, step therapy will be required for this drug. See Section 4 for details. |
$48.29 |
$16.21 |
$0.00 |
{insert name of second drug} 50 mg caps 03/21/20, ABC Pharmacy Rx# 671142913332, 30 day supply NOTE: Effective December 1, 2020, this drug will be removed from our drug list. See Section 4 for details. |
$72.34 |
$22.60 |
$0.00 |
{insert name of third drug} 0.5 mg 03/25/20, ABC Pharmacy Rx# 444025344660, 30 day supply NOTE: Effective December 1, 2020, this drug will be moved from cost-sharing tier 2 to a higher cost-sharing tier (tier 3). See Section 4 for details. |
$2.80 |
$5.00 |
$0.00 |
{NOTE: This example shows only the first part of Chart 1. The rest of the chart is not included.}
PRA Disclosure Statement According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this collection is 0938-0964. The time required to complete this information collection is estimated to average 200 hours per response based on the time and effort necessary to disclose and disseminate plan information and materials. If you have any comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please write to CMS, 7500 Security Boulevard, Attn: PRA Reports Clearance Officer, Baltimore, Maryland 21244-1850.
CMS does not discriminate in its programs and activities: To request this form in an accessible format (e.g., Braille, Large Print, Audio CD) contact your Medicare Drug Plan. If you need assistance contacting your plan, call: 1-800-MEDICARE.
Form CMS-10141 OMB Control No. 0938-0964 (Expires 11/30/2021)
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Jeanne McGee |
File Modified | 0000-00-00 |
File Created | 2021-01-15 |